Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Cannabidiol (CBD) Pet Market
Cannabidiol Pet Market size was valued at USD 693.4 million in 2023 and is estimated to grow at 18.2% CAGR from 2024 to 2032, driven by the growing pet ownership coupled with increasing awareness and acceptance of the potential therapeutic benefits of hemp-derived CBD for pets.
As more studies suggested that CBD can help manage various conditions such as anxiety, chronic pain, arthritis, and seizures in pets, pet owners are becoming more willing to explore CBD products as a natural and holistic alternative to traditional medications. For instance, a study by Cornell University College of Veterinary Medicine revealed that over 80% of dogs affected by arthritis experienced less pain after using CBD supplements. This promising result gained traction among pet owners, thereby surging the demand for CBD products as a viable treatment option. Thus, growing awareness is expected to attract opportunities in the market.
CBD pet refers to products containing CBD specifically formulated for pets. CBD is a non-psychoactive compound derived from the cannabis plant known for its potential therapeutic effects, including anti-inflammatory, analgesic, and anti-anxiety properties. CBD pet products are designed to be safe for animal consumption and are typically available in various forms such as oils, treats, capsules, and topical creams.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Cannabidiol Pet Market Size in 2023: | USD 693.4 Million |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 18.2% |
2032 Value Projection: | USD 3.1 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 160 |
Tables, Charts & Figures: | 311 |
Segments covered: | Pet Type, Product Type, Application, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|